SERPINH1 and colorectal carcinoma: Research showed that SERPINH1 could be a serum marker in diagnosis and prognosis assessment of GC (Liu et al., 2021) and potentially be the noninvasive biomarker reflecting the adenoma and carcinoma, especially CRC (Zhang et al., 2021).